// App-Quantinova.ai

e13521 : Genomic profiling and precision medicine in 3,745 patients with advanced cancer.

Researchers

Presenter

  • Apostolia Maria Tsimberidou

Principal Investigators

  • Jennifer J. Wheler

  • Stacy L. Moulder

  • Vivek Subbiah

  • Daniel D. Karp

  • Funda Meric-Bernstam

  • Patrick Hwu

  • Merrill S. Kies

  • Vincent A. Miller

  • Russell Broaddus

  • Aung Naing

  • Siqing Fu

  • Razelle Kurzrock

  • Sarina Anne Piha-Paul

  • Filip Janku

  • Ralph Zinner

  • Kenneth R. Hess

  • Gerald Steven Falchook

  • David S. Hong

Medical Centers

  • Department of Investigational Cancer Therapeutics (Phase 1 Program), The University of Texas MD Anderson Cancer Center, Houston, TX

  • The University of Texas MD Anderson Cancer Center, Houston, TXDepartment of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TXMoores Cancer Center - University of California San Diego, La Jolla, CA

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Foundation Medicine, Inc, Cambridge, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Methadone hydrochloride

Outcome

  • Positive

Study Design

  • randomized

Phase

  • NA

Study Id's

  • NCT00851032

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved